drugset / Trial / NCT01270282

Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus

NCT01270282

Phase 2 Completed 82 enrolled Auris Medical AG
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to evaluate the therapeutic benefit and safety of intratympanic AM-101 injections in comparison to placebo in the treatment of persistent acute inner ear tinnitus.

Timeline

Start
2011-02
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.81 mg/ml Other

Indications